RETRANSMISSION UniDoc Announces LIFE Offering

Executive Summary

• UniDoc Health Corp. announced a non‑brokered private placement offering up to 10 million units for gross proceeds of up to $1,500,000.
• Each unit consists of one common share and one transferable warrant to purchase an additional share at $0.25 per share, exercisable for 36 months after closing.
• Proceeds are earmarked for inventory, marketing & investor‑relations services, working capital, and general corporate purposes; the offering is expected to close on or about October 15, 2025 (or within 45 days of October 2, 2025).

Key Details

• Units Offered: Up to 10,000,000 units at $0.15 per unit.
• Total Gross Proceeds Target: $1,500,000.
• Unit Composition:
• 1 common share of UniDoc Health Corp.
• 1 transferable common‑share purchase warrant (right to acquire one additional common share at $0.25 per share).
• Warrant Terms: Exercise price $0.25, exercisable for 36 months post‑closing.
• Use of Proceeds: Inventory, marketing and investor‑relations services, working capital, and general corporate purposes.
• Exemption Used: Listed issuer financing exemption under Part 5A of NI 45‑106 (prospectus exempt) in all Canadian provinces/territories except Quebec.
• Resale Restrictions: Units issued to Canadian resident subscribers are not subject to resale restrictions under the exemption.
• Closing Date: Expected on or about October 15, 2025, or any date within 45 days of October 2, 2025, subject to customary conditions (including CSE approval).
• Contact Information: Investor Relations – Tel: +1 778‑383‑6731; Email: [email protected].

Notable Quotes

(No direct quotes from management were included in the release.)